Roche Palo Drug Patent Portfolio
Roche Palo owns 1 orange book drug protected by 2 US patents Given below is the list of Roche Palo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5688529 | Mycophenolate mofetil high dose oral suspensions | 18 Nov, 2014 | Expired |
| US5543408 | Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof | 15 Sep, 2013 | Expired |
Roche Palo's Family Patents
Roche Palo Drug List
Given below is the complete list of Roche Palo's drugs and the patents protecting them.
1. Cellcept
Cellcept is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5688529 | Mycophenolate mofetil high dose oral suspensions |
18 Nov, 2014
(10 years ago)
| Expired |
| US5543408 | Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
15 Sep, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cellcept's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List